Last edition
News about "MoU Likely at iPHEX 2025"
India, Myanmar Explore Fast-Track Pharma Approvals; MoU Likely at iPHEX 2025
India is currently a major supplier of medicines to Myanmar, meeting nearly 60% of the country’s pharmaceutical needs. The MoU will aim to expand bilateral cooperation in pharma trade and regulatory alignment.
MoU Likely At IPHEX 2025 | 04/07/2025 | By Darshana | 176
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members